Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation

Background: The New Medicine Service (NMS) was introduced to community pharmacies in England in October 2011. The NMS aims to improve adherence to new medicines in patients with selected long term conditions. The service consists of two follow-up consultations within 1 month in addition to usual car...

Full description

Bibliographic Details
Main Authors: Wells, Katharine M., Thornley, Tracey, Boyd, Matthew J., Boardman, Helen F.
Format: Article
Published: Elsevier 2014
Online Access:https://eprints.nottingham.ac.uk/49246/
_version_ 1848797955483500544
author Wells, Katharine M.
Thornley, Tracey
Boyd, Matthew J.
Boardman, Helen F.
author_facet Wells, Katharine M.
Thornley, Tracey
Boyd, Matthew J.
Boardman, Helen F.
author_sort Wells, Katharine M.
building Nottingham Research Data Repository
collection Online Access
description Background: The New Medicine Service (NMS) was introduced to community pharmacies in England in October 2011. The NMS aims to improve adherence to new medicines in patients with selected long term conditions. The service consists of two follow-up consultations within 1 month in addition to usual care. Objectives: This study explored community pharmacist and superintendent pharmacist views and experiences of the NMS in the 5 weeks prior to its implementation to identify potential facilitators and barriers to its success. The study also investigated participant experiences of the introduction and provision of existing pharmacy services in order to contrast with the implementation of the NMS. Methods: This study consisted of four focus groups with a total of 15 community pharmacists representing locums and employees of small, medium and large chain pharmacies. In addition, 5 semi-structured interviews were conducted with superintendent pharmacists representing independent, small chain, supermarket and large multiple pharmacies. Data were audio-recorded, transcribed verbatim and thematically analyzed. Results: Both pharmacists and superintendent pharmacists were positive about the NMS and identified potential benefits for patients and the pharmacy profession. Awareness of the service was high, however, some confusion between the NMS and changes to Medicine Use Reviews was evident in all focus groups due to their similarity and coincidental implementation. This confusion was not observed in the interviews with superintendent pharmacists. Participants identified pharmacists' positive attitude, the similarity to current practice and the self-accreditation procedure as potential facilitators to service implementation. Potential barriers identified included a perceived lack of interest and awareness by GPs of the service, and the payment structure. Participants were concerned about the speed of implementation, and the absence of some materials needed prior to the start of the service. Conclusions: Participants were enthusiastic about the potential of the NMS to benefit patients and the pharmacy profession. Participants were able to identify several potential barriers and facilitators to the provision of the service. It remains to be seen whether the factors identified affected the early implementation of the service.
first_indexed 2025-11-14T20:12:06Z
format Article
id nottingham-49246
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T20:12:06Z
publishDate 2014
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling nottingham-492462020-05-04T16:41:11Z https://eprints.nottingham.ac.uk/49246/ Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation Wells, Katharine M. Thornley, Tracey Boyd, Matthew J. Boardman, Helen F. Background: The New Medicine Service (NMS) was introduced to community pharmacies in England in October 2011. The NMS aims to improve adherence to new medicines in patients with selected long term conditions. The service consists of two follow-up consultations within 1 month in addition to usual care. Objectives: This study explored community pharmacist and superintendent pharmacist views and experiences of the NMS in the 5 weeks prior to its implementation to identify potential facilitators and barriers to its success. The study also investigated participant experiences of the introduction and provision of existing pharmacy services in order to contrast with the implementation of the NMS. Methods: This study consisted of four focus groups with a total of 15 community pharmacists representing locums and employees of small, medium and large chain pharmacies. In addition, 5 semi-structured interviews were conducted with superintendent pharmacists representing independent, small chain, supermarket and large multiple pharmacies. Data were audio-recorded, transcribed verbatim and thematically analyzed. Results: Both pharmacists and superintendent pharmacists were positive about the NMS and identified potential benefits for patients and the pharmacy profession. Awareness of the service was high, however, some confusion between the NMS and changes to Medicine Use Reviews was evident in all focus groups due to their similarity and coincidental implementation. This confusion was not observed in the interviews with superintendent pharmacists. Participants identified pharmacists' positive attitude, the similarity to current practice and the self-accreditation procedure as potential facilitators to service implementation. Potential barriers identified included a perceived lack of interest and awareness by GPs of the service, and the payment structure. Participants were concerned about the speed of implementation, and the absence of some materials needed prior to the start of the service. Conclusions: Participants were enthusiastic about the potential of the NMS to benefit patients and the pharmacy profession. Participants were able to identify several potential barriers and facilitators to the provision of the service. It remains to be seen whether the factors identified affected the early implementation of the service. Elsevier 2014-01-30 Article PeerReviewed Wells, Katharine M., Thornley, Tracey, Boyd, Matthew J. and Boardman, Helen F. (2014) Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation. Research in Social and Administrative Pharmacy, 10 (1). pp. 58-71. ISSN 1551-7411 http://www.sciencedirect.com/science/article/pii/S155174111300048X?via%3Dihub doi:10.1016/j.sapharm.2013.03.003 doi:10.1016/j.sapharm.2013.03.003
spellingShingle Wells, Katharine M.
Thornley, Tracey
Boyd, Matthew J.
Boardman, Helen F.
Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation
title Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation
title_full Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation
title_fullStr Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation
title_full_unstemmed Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation
title_short Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation
title_sort views and experiences of community pharmacists and superintendent pharmacists regarding the new medicine service in england prior to implementation
url https://eprints.nottingham.ac.uk/49246/
https://eprints.nottingham.ac.uk/49246/
https://eprints.nottingham.ac.uk/49246/